While CBD is known for its relaxing effects without being psychoactive, HHC (hexahydrocannabinol) is a lesser-known molecule that can induce psychotropic effects. Let's delve into the differences between these two substances from the same family, but with contrasting properties.
The properties of CBD: relaxation without altering perception
CBD (cannabidiol), extracted from the hemp plant, is known and appreciated for its numerous benefits to the body, including:
- Analgesic effects: pain relief
- Anti-inflammatory effects: reduction of inflammation and redness
- Anxiety and stress reduction
- Sleep improvement
- Immune system support
Unlike THC (tetrahydrocannabinol), the main active agent in cannabis which causes feelings of euphoria and intoxication, CBD does not alter the consciousness or perception of users, hence its legalization in many countries, including France.
HHC, a cousin of THC with psychotropic effects
Unlike CBD, HHC is known for its potency, due to its psychoactive effects. Unlike CBD, HHC can produce sensations similar to consuming THC, the active ingredient in a traditional joint.
Because of these effects, French authorities have decided to classify HHC as a narcotic. Unlike CBD, which does not alter perception or consciousness, HHC can temporarily alter an individual's mental state. Consequently, the French National Agency for Medicines and Health Products Safety (ANSM) reacted by classifying it as a narcotic, thus prohibiting all forms of marketing and consumption in France.
Detection of HHC in body fluids
HHC can indeed be detected in bodily fluids, including saliva, usually during tests designed to detect the presence of THC. Although it is a distinct molecule, current tests are accurate enough to identify HHC in blood and saliva using specific markers.
The legality of HHC: classified as a narcotic since 2023
Since June 13, 2023, hepatitis C (HHC) has been legally classified as a narcotic in France. This decision, applauded by the Minister of Health, resulted from the classification by the ANSM (French National Agency for Medicines and Health Products Safety), thus responding to growing concerns about the effects of this substance. Consequently, the production, marketing, and use of HHC are now prohibited.
Other cannabinoid substances under study
In addition to CBD and HHC, other substances such as CBG (cannabigerol) and variations like H4CBD are also attracting interest. Each cannabinoid has distinct properties:
- Some, like CBD, are legal and appreciated for their benefits without psychotropic effects.
- Others, such as HHC, present potential risks leading to legal restrictions.
In conclusion, although CBD and HHC share a common origin, their health implications, effects on the body, and legal status are radically different.
Editor-in-Chief specializing in CBD
Julien, born on July 17, 1978, in the Paris region, is a prominent writer and expert in the field of CBD products. Following his studies, Julien developed a passion for natural remedies, including CBD. In 2022, he joined the CBD.fr team as an expert and regular contributor. Thanks to his scientific expertise and clear writing style, Julien helps demystify the complexities of CBD, while highlighting its benefits and potential applications through his articles and conference presentations.
